Skip to main content
logo
Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.070
-0.145 (-11.93%)
At close: Sep 23, 2026, 4:00 PM EDT
1.095
+0.025 (2.34%)
Pre-market: Sep 24, 2026, 5:08 AM EDT

CNTB Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Revenue
2.950.0626.03---
Revenue Growth
50.28%-99.75%----
Gross Profit
2.950.0626.03---
Operating Income
-70.41-58.07-19.25-69.06-116.36-97.66
Net Income
-68.99-55.48-15.63-62.11-118.09-202.27
Earnings Per Share
-1.19-1.00-0.28-1.13-2.15-3.88
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Investments
31.4944.3493.71118.3152.47267.72
Total Debt
0.60.690.180.470.430.13
Net Cash (Debt)
30.8943.6593.53117.84152.04267.59
Net Cash Growth
-56.43%-53.33%-20.63%-22.49%-43.18%-
Net Cash Per Share
0.530.781.692.142.765.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Operating Cash Flow
-60.58-51.21-23.61-47.74-101.52-84.32
Capital Expenditures
-0.05-0.43-0.75-0.08-4.41-3.83
Free Cash Flow
-60.63-51.64-24.36-47.82-105.93-88.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Gross Margin
100.00%100.00%100.00%---
Operating Margin
-2384.49%-90740.63%-73.95%---
Pretax Margin
-2329.66%-86379.69%-59.17%---
Profit Margin
-2336.30%-86687.50%-60.03%---
FCF Margin
-2053.27%-80687.50%-93.58%---

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
PS Ratio
22.822463.25----